Earlier antiretroviral therapy initiation and decreasing mortality among HIV-infected infants initiating antiretroviral therapy within 3 months of age in South Africa, 2006–2017
The Pediatric Infectious Disease Journal Jan 16, 2020
Iyun V, Technau KG, Eley B, et al. - Given the rapid scaling up of early infant diagnosis of HIV and antiretroviral therapy (ART), researchers investigated how expanded access to early ART has affected the characteristics and outcomes of infants initiating ART. They assessed 1,847 infants who started ART at a median age of 60 days between 2006 and 2017 from 9 cohorts within the International epidemiologic Databases to Evaluate AIDS-Southern Africa collaboration. Infants with HIV are starting ART younger and healthier with associated drops in mortality. However, in recent years, undesirably high risk of mortality remained. Findings suggest the necessity for focused interventions to optimize the benefits of earlier diagnosis and treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries